rheum Q&As

Q&As

Alexis Ogdie, MD, on Achieving Minimal Disease Activity Among Patients With PsA

10/04/2023

Dr Ogdie answers our questions about achieving minimal disease activity among patients with psoriatic arthritis treated with biologic and targeted synthetic DMARDs.

Dr Ogdie answers our questions...

10/04/2023

Rheumatology & Arthritis

Q&A

Ching-Lung Cheung, PhD, on the Health Burden of Osteoporotic Fractures Among the Aging Population

09/29/2023

Dr Cheung agreed to answer a few question about his recent study highlighting an urgent need for better strategies in hip fracture prevention and care.

Dr Cheung agreed to answer a few...

09/29/2023

Rheumatology & Arthritis

Q&A

Monica Schwartzman, MD, on Medication Preferences Among Patients With PsA

08/21/2023

Dr Schwartzman answered our questions about her recent study of what patients with psoriatic arthritis want most from their medical therapy.

Dr Schwartzman answered our...

08/21/2023

Rheumatology & Arthritis

Q&A

Lars Klareskog, MD, on the Study of Occupational Exposures and Risk of RA

08/08/2023

Dr Klareskog agreed to answer a few questions about this study on whether occupational inhalable agents present major risks in the development of rheumatoid arthritis, particularly among smokers and among those with a genetic predisposition...

Dr Klareskog agreed to answer a...

08/08/2023

Rheumatology & Arthritis

Q&As

Optimizing Patient Care: Collaboration Between Dermatology and Rheumatology

06/20/2023

Jessica Garlewicz, Associate Digital Editor

A recent abstract published in the Journal of Cutaneous Medicine and Surgery reviewed and created a risk stratification strategy for early referral of patients with psoriatic arthritis.

A recent abstract published in...

06/20/2023

The Dermatologist

Q&As

Jennifer L Barton, MD, on Goal Elicitation for Patients with RA

01/06/2023

In this Q&A, Dr. Barton discusses the development of a goal elicitation tool for patients with rheumatoid arthritis.

In this Q&A, Dr. Barton...

01/06/2023

Rheumatology & Arthritis

Q&A

Wellness in Rheumatic Diseases: A Conversation with Saundra Jain, MS, PsyD, and Andrew Laster, MD

09/30/2022

In this Q&A, Saundra Jain, MS, PsyD, and Andrew Laster, MD, discuss the concept of wellness in the context of rheumatic diseases and inflammatory arthritis.

In this Q&A, Saundra Jain, MS,...

09/30/2022

Rheumatology & Arthritis

Q&A

Dana Villmore, PhD, Pa-C, on Treating Fibromyalgia in a Primary Care Setting

07/20/2022

In this Q&A, Dana Villmore, PhD, Pa-C, discusses the diagnosis and management of fibromyalgia for primary care providers.

In this Q&A, Dana Villmore, PhD,...

07/20/2022

Rheumatology & Arthritis

Q&A

Betty Hsiao, MD, on Patient Conceptualization of RA Treatment

07/19/2022

Dr Betty Hsiao, from the Yale New Haven Medical Center and a medical advisor to CreakyJoints, presented an abstract at EULAR 2022 on understanding heterogeneity in patients' conceptualization of treatment for rheumatoid arthritis.

Dr Betty Hsiao, from the Yale...

07/19/2022

Rheumatology & Arthritis

Q&A

Alexis Ogdie, MD, on a Treat To Target Approach to Psoriatic Arthritis

06/29/2022

How beneficial is achieving minimal disease activity for patients with psoriatic arthritis? Alexis Ogdie, MD, of the University of Pennsylvania, answers some questions about her research into this subject in this Q&A.

How beneficial is achieving...

06/29/2022

Rheumatology & Arthritis

Stay in the Know

Rheumatology & Arthritis Newsletter

Q&As

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products